Deficit of GATA-2 transcription factor: new immunodeficiency syndrome with broad phenotype. First patients diagnosed in the Czech Republic and review of the literature
Authors:
A. Janda 1; E. Mejstříková 2; U. Salzer 1; J. Grimová 3; T. Svobodová 4; M. Suková 2; M. Nováková 2; P. Hubáček 2,9; Z. Zemanová 5; J. Čermák 6; Z. Černá 7; A. Vítek 6; A. Šedivá 8; O. Hrušák 2; J. Starý 2
Authors place of work:
Centre of Chronic Immunodeficiency (CCI), University Medical Centre and University of Freiburg, Freiburg im Breisgau, Německo
1; Klinika dětské hematologie a onkologie UK 2. LF a FN Motol, Prahapřednosta prof. MUDr. J. Starý, DrSc.
2; Onkologická klinika UK 1. LF a Fakultní Thomayerovy nemocnice, Prahapřednosta MUDr. T. Buchler, Ph. D.
3; Pediatrická klinika UK 2. LF a FN Motol, Prahapřednosta prof. MUDr. J. Lebl, CSc.
4; Ústav lékařské biochemie a laboratorní diagnostiky UK 1. LF a VFN, Prahapřednosta prof. MUDr. T. Zima, DrSc., MBA
5; Ústav hematologie a krevní transfuze, Prahaředitel prof. MUDr. M. Trněný, CSc.
6; Dětská klinika Lékařské fakulty Univerzity Karlovy, Plzeňpřednosta doc. MUDr. J. Kobr, Ph. D.
7; Ústav imunologie UK 2. LF a FN Motol, Prahapřednostka prof. MUDr. J. Bartůňková, DrSc., MBA
8; Ústav lékařské mikrobiologie UK 2. LF a FN Motol, Prahapřednosta doc. MUDr. P. Dřevínek, Ph. D.
9
Published in the journal:
Čes-slov Pediat 2013; 68 (2): 101-112.
Category:
Case Report
Summary
Defects in the zinc-finger transcription factor GATA-2 gene have been recently identified in variable phenotypes associated with myeloid malignancies - myelodysplastic syndrome and acute myeloid leukaemia (MDS/AML): DCML (dendritic cell, monocyte, B-lymphocyte and NK-lymphocyte) deficiency or MonoMAC syndrome (monocytopenia with Mycobaterium avium complex infections), Emberger syndrome (early onset primary lymphoedema, multiple warts, sensorineural deafness, dysmorphism); and familial MDS/AML with no additional known phenotype.
In the Czech Republic there have been 2 patients diagnosed with GATA-2 deficiency so far. The first patient was investigated at the age of 12 years for recurrent urinary tract infections, aphtous stomatitis, herpetic skin infections and bronchial asthma; leukopenia, mild macrocytic anaemia and markedly low number of B lymphocytes with normal immunoglobulin levels were found. In the following 10 years bicytopenia progressed into a hypoplastic MDS. The girl underwent successful transplantation of haematopoietic stem cells from her HLA-identical healthy sister. Retrospectively, a heterozygous mutation (c.1187 G>A, p.R396Q) in GATA-2 has been identified. The second patient is 17 year-old boy investigated for an advanced interstitial pulmonary process with cystic remodelling of pulmonary parenchyma accompanied by signs of vasculitis. Suspicion of GATA-2 genetic defect was based on profound monocytopenia and B-cell lymphopenia. By molecular genetic analysis of GATA-2 heterozygous mutation (c.1081 C>T, p.R361C) was revealed.
Our experience corresponds with the published data on the broad phenotypic variability in patients with GATA-2 mutations. Establishment of the diagnosis of GATA-2 deficiency should lead to closer follow-up of the affected individuals and earlier allogeneic haematopoietic stem cell transplantation in case of clonal progression (MDS/AML).
Key words:
primary immunodeficiency, GATA-2 deficiency, MonoMAC, dendritic cell, monocyte, B lymphocyte, and natural killer lymphocyte deficiency (DCML), Emberger syndrome; pulmonary alveolar proteinosis, haematopoietic stem cell transplantation
Zdroje
1. Al-Herz W, et al. Primary immunodeficiency diseases: an update on the classification from the international union of immunological societies expert committee for primary immunodeficiency. Front Immunol 2011; 2: 54.
2. Bresnick EH, et al. Master regulatory GATA transcrip-tion factors: mechanistic principles and emerging links to hematologic malignancies. Nucleic Acids Res 2012; 40 (13): 5819–5831.
3. Rodrigues NP, et al. GATA-2 mediated regulation of normal hematopoietic stem/progenitor cell function, myelodysplasia and myeloid leukemia. Int J Biochem Cell Biol 2012; 44 (3): 457–460.
4. Hahn CN, et al. Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia. Nat Genet 2011; 43 (10): 1012–1017.
5. Hsu AP, et al. Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome. Blood 2011; 118 (10): 2653–2655.
6. Dickinson RE, et al. Exome sequencing identifies GATA-2 mutation as the cause of dendritic cell, monocyte, B and NK lymphoid deficiency. Blood 2011; 118 (10): 2656–2658.
7. Bigley V, Collin M. Dendritic cell, monocyte, B and NK lymphoid deficiency defines the lost lineages of a new GATA-2 dependent myelodysplastic syndrome. Haematologica 2011; 96 (8): 1081–1083.
8. Ostergaard P, et al. Mutations in GATA2 cause primary lymphedema associated with a predisposition to acute myeloid leukemia (Emberger syndrome). Nat Genet 2011; 43 (10): 929–931.
9. Kazenwadel J, et al. Loss-of-function germline GATA2 mutations in patients with MDS/AML or MonoMAC syndrome and primary lymphedema reveal a key role for GATA2 in the lymphatic vasculature. Blood 2012; 119 (5): 1283–1291.
10. Vinh DC, et al. Autosomal dominant and sporadic monocytopenia with susceptibility to mycobacteria, fungi, papillomaviruses, and myelodysplasia. Blood 2010; 115 (8): 1519–1529.
11. Bigley V, et al. The human syndrome of dendritic cell, monocyte, B and NK lymphoid deficiency. J Exp Med 2011; 208 (2): 227–234.
12. Calvo KR, et al. Myelodysplasia in autosomal dominant and sporadic monocytopenia immunodeficiency syndrome: diagnostic features and clinical implications. Haematologica 2011; 96 (8): 1221–1225.
13. Zhang SJ, Shi JY, Li JY. GATA-2 L359 V mutation is exclusively associated with CML progression but not other hematological malignancies and GATA-2 P250A is a novel single nucleotide polymorphism. Leuk Res 2009; 33 (8): 1141–1143.
14. Lasbury ME, et al. Effect of transcription factor GATA-2 on phagocytic activity of alveolar macrophages from Pneumocystis carinii-infected hosts. Infect Immun 2003; 71 (9): 4943–4952.
15. Seymour JF, Presneill JJ. Pulmonary alveolar proteinosis: progress in the first 44 years. Am J Respir Crit Care Med 2002; 166 (2): 215–235.
16. Dirksen U, et al. Human pulmonary alveolar proteinosis associated with a defect in GM-CSF/IL-3/IL-5 receptor common beta chain expression. J Clin Invest 1997; 100 (9): 2211–2217.
17. Inoue Y, et al. Characteristics of a large cohort of patients with autoimmune pulmonary alveolar proteinosis in Japan. Am J Respir Crit Care Med 2008; 177 (7): 752–762.
18. Bert AG, et al. A modular enhancer is differentially regulated by GATA and NFAT elements that direct different tissue-specific patterns of nucleosome positioning and inducible chromatin remodeling. Mol Cell Biol 2007; 27 (8): 2870–2885.
19. German Z, et al. Molecular basis of cell-specific endothelial nitric-oxide synthase expression in airway epithelium. J Biol Chem 2000; 275 (11): 8183–8189.
20. Liew E, Owen C. Familial myelodysplastic syndromes: a review of the literature. Haematologica 2011; 96 (10): 1536–1542.
21. Bodor C, et al. Germ-line GATA2 p.THR354MET mutation in familial myelodysplastic syndrome with acquired monosomy 7 and ASXL1 mutation demonstrating rapid onset and poor survival. Haematologica 2012; 97 (6): 890–894.
22. Cuellar-Rodriguez J, et al. Successful allogeneic hematopoietic stem cell transplantation for GATA2 deficiency. Blood 2011; 118 (13): 3715–3720.
23. Rosenzweig SD, Holland SM. Defects in the interferon-gamma and interleukin-12 pathways. Immunol Rev 2005; 203: 38–47.
24. Hambleton S, et al. IRF8 mutations and human dendritic-cell immunodeficiency. N Engl J Med 2011; 365 (2): 127–138.
25. Chatila TA, et al. JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity – allergic disregulation syndrome. J Clin Invest 2000; 106 (12): R75–81.
26. Holland SM, et al. STAT3 mutations in the hyper-IgE syndrome. N Engl J Med 2007; 357 (16): 1608–1619.
27. Liu L, et al. Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis. J Exp Med 2011; 208 (8): 1635–1648.
Štítky
Neonatology Paediatrics General practitioner for children and adolescentsČlánok vyšiel v časopise
Czech-Slovak Pediatrics
2013 Číslo 2
- What Effect Can Be Expected from Limosilactobacillus reuteri in Mucositis and Peri-Implantitis?
- The Importance of Limosilactobacillus reuteri in Administration to Diabetics with Gingivitis
Najčítanejšie v tomto čísle
- Development of gut microbiota and risks of probiotics use in immunocompromised children
- A girl with karyotype 46, XY – case report
- Deficit of GATA-2 transcription factor: new immunodeficiency syndrome with broad phenotype. First patients diagnosed in the Czech Republic and review of the literature
- A survey of patients diagnosed with X-linked lymphoproliferation disease (XLP) in the Czech Republic and Slovakia